9-fluoro-2-[2-(4-fluorophenyl)ethyl]-4-(phenoxymethyl)-3,4-dihydro-5,1λ6,2-benzoxathiazepine 1,1-dioxide
C23H21F2NO4S — CID 45479921
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-fluoro-2-[2-(4-fluorophenyl)ethyl]-4-(phenoxymethyl)-3,4-dihydro-5,1λ6,2-benzoxathiazepine 1,1-dioxide
9-fluoro-2-[2-(4-fluorophenyl)ethyl]-4-(phenoxymethyl)-3,4-dihydro-5,1λ6,2-benzoxathiazepine 1,1-dioxide (PubChem CID 45479921) has the molecular formula C23H21F2NO4S and a molecular weight of 445.49 g/mol. Its IUPAC name is 9-fluoro-2-[2-(4-fluorophenyl)ethyl]-4-(phenoxymethyl)-3,4-dihydro-5,1λ6,2-benzoxathiazepine 1,1-dioxide.
Molecular Properties
| Compound Name | 9-fluoro-2-[2-(4-fluorophenyl)ethyl]-4-(phenoxymethyl)-3,4-dihydro-5,1λ6,2-benzoxathiazepine 1,1-dioxide |
|---|---|
| PubChem CID | 45479921 |
| Molecular Formula | C23H21F2NO4S |
| Molecular Weight | 445.49 g/mol |
| Exact Mass | 445.12 |
| IUPAC Name | 9-fluoro-2-[2-(4-fluorophenyl)ethyl]-4-(phenoxymethyl)-3,4-dihydro-5,1λ6,2-benzoxathiazepine 1,1-dioxide |
| SMILES | O=S1(=O)c2c(F)cccc2OC(COc2ccccc2)CN1CCc1ccc(F)cc1 |
| InChI | InChI=1S/C23H21F2NO4S/c24-18-11-9-17(10-12-18)13-14-26-15-20(16-29-19-5-2-1-3-6-19)30-22-8-4-7-21(25)23(22)31(26,27)28/h1-12,20H,13-16H2 |
| InChIKey | SHLWFKBDOHURCH-UHFFFAOYSA-N |
| XLogP | 4.04 |
| TPSA | 55.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.49 |
| LogP ≤ 5 | 4.04 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 45479921 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.